Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BMS-986453 |
Synonyms | |
Therapy Description |
BMS-986453 comprises T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting TNFRSF17 (BCMA) and GPRC5D, which potentially induces toxicity in TNFRSF17 (BCMA) and GPRC5D-expressing tumor cells (NCI Drug Dictionary). |